Review
Open access
Oct 2026
Low-grade serous ovarian cancer: 2026 expert consensus report.
Low-grade serous ovarian carcinoma (LGSOC) is a rare epithelial malignancy characterized by frequent mitogen-activated protein kinase (MAPK) pathway alterations, hormone receptor expression, relative resistance to cytotoxic chemotherapy, and a prolonged, relapsing clinical course. Since publication of the 2023 internat...
R. Grisham, B. Slomovitz, V. Podder et al.
· Gynecologic Oncology · 0 citations